BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shata MTM, Abdel-Hameed EA, Rouster SD, Yu L, Liang M, Song E, Esser MT, Shire N, Sherman KE. HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles. Pathog Immun 2019;4:39-65. [PMID: 30815625 DOI: 10.20411/pai.v4i1.267] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Paximadis M, Perez Patrigeon S, Rajasuriar R, Tatoud R, Scully E, Arbuthnot P. Hepatitis B and HIV-1 2019 IAS Cure Forum: lessons and benefits from interdisciplinary research. Journal of Virus Eradication 2019;5:234-44. [DOI: 10.1016/s2055-6640(20)30027-3] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Kurma K, Boizard-Moracchini A, Galli G, Jean M, Vacher P, Blanco P, Legembre P. Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target? Biochim Biophys Acta Rev Cancer 2021;1876:188596. [PMID: 34324950 DOI: 10.1016/j.bbcan.2021.188596] [Reference Citation Analysis]
3 Bekçibaşı M, Deveci Ö, Oğuz A, Bozkurt F, Dayan S, Çelen MK. Serum TNF-α, IL-1β, and IL-6 levels in chronic HBV-infected patients. Int J Clin Pract 2021;75:e14292. [PMID: 33930244 DOI: 10.1111/ijcp.14292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Osasona OG, Adewale-Fashoro O, Olumade TJ, Oguzie J, George U, Ariyo OE, Oguntoye OO. Comparative serologic profiles of hepatitis B Virus (HBV) between HIV/HBV co-infected and Hbv mono-infected patients in Ile-Ife, Nigeria. J Immunoassay Immunochem 2021;:1-15. [PMID: 34029499 DOI: 10.1080/15321819.2021.1924197] [Reference Citation Analysis]
5 Yuan S, Jiang SC, Zhang ZW, Fu YF, Hu J, Li ZL. Quantification of Cytokine Storms During Virus Infections. Front Immunol 2021;12:659419. [PMID: 34079547 DOI: 10.3389/fimmu.2021.659419] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Audsley J, Sasadeusz J. Challenges and opportunities for hepatitis B cure in the setting of HIV--hepatitis B virus co-infection. Curr Opin HIV AIDS 2020;15:193-9. [PMID: 32141889 DOI: 10.1097/COH.0000000000000624] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hakim MS, Rahmadika N, Jariah ROA. Expressions of inhibitory checkpoint molecules in acute and chronic HBV and HCV infections: Implications for therapeutic monitoring and personalized therapy. Rev Med Virol 2019;30. [DOI: 10.1002/rmv.2094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]